STAT+: Lobbyists and trade groups fight to shape how states regulate medical AI
Reported by STAT News · all stories from statnews.com
Editorial digest
Various lobbying groups and trade organizations are actively engaged in efforts to help define how individual states will oversee medical AI technologies. Their advocacy seeks to shape the emerging regulatory environment.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom10/8/2026
STAT+: AI for breast cancer risk prediction goes DTC, regulatory cloud over Utah sandbox, and AI psychosis
AI for breast cancer risk is now direct-to-consumer; regulatory concerns and AI-induced psychosis are also discussed.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.
- Trusted health newsroom9/9/2026
STAT+: U.K. unveils recommendations for regulating AI in medicine
The U.K. has published guidelines for regulating AI in medical applications.
- Trusted health newsroom9/14/2026
STAT+: How $500 explains Republican health policy, and the GLP-1 Rx wave
A specific financial figure illuminates Republican health policy and the rise of GLP-1 prescriptions.
- Trusted health newsroom9/15/2026
STAT+: Medicare’s AI prior authorization pilot was rushed and full of problems, new documents reveal
Medicare's AI prior authorization program faced issues and was launched too quickly, according to new details.
- Trusted health newsroom8/4/2026
STAT+: Are AI scribes medical devices? U.K. regulator weighs in
The U.K. regulator is evaluating AI scribes as medical devices.